pyridoxal phosphate has been researched along with Spasm in 2 studies
Pyridoxal Phosphate: This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
pyridoxal 5'-phosphate : The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal.
Spasm: An involuntary contraction of a muscle or group of muscles. Spasms may involve SKELETAL MUSCLE or SMOOTH MUSCLE.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Although several studies have reported serious adverse events following PLP treatment, no study has investigated the risk factors for such occurrences." | 5.91 | Identifying risk factors for adverse events of pyridoxal phosphate in infantile epileptic spasms syndrome. ( Arai, Y; Kanai, S; Maegaki, Y; Noma, H; Ohta, K; Okanishi, T; Sunada, H, 2023) |
| " Although several studies have reported serious adverse events following PLP treatment, no study has investigated the risk factors for such occurrences." | 1.91 | Identifying risk factors for adverse events of pyridoxal phosphate in infantile epileptic spasms syndrome. ( Arai, Y; Kanai, S; Maegaki, Y; Noma, H; Ohta, K; Okanishi, T; Sunada, H, 2023) |
| "3." | 1.29 | P2-purinoceptors mediating spasm of the isolated uterus of the non-pregnant guinea-pig. ( Hollingsworth, M; Piper, AS, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, Y | 1 |
| Okanishi, T | 1 |
| Kanai, S | 1 |
| Ohta, K | 1 |
| Sunada, H | 1 |
| Noma, H | 1 |
| Maegaki, Y | 1 |
| Piper, AS | 1 |
| Hollingsworth, M | 1 |
2 other studies available for pyridoxal phosphate and Spasm
| Article | Year |
|---|---|
Identifying risk factors for adverse events of pyridoxal phosphate in infantile epileptic spasms syndrome.
Topics: Humans; Infant; Pyridoxal Phosphate; Retrospective Studies; Risk Factors; Spasm; Spasms, Infantile; | 2023 |
P2-purinoceptors mediating spasm of the isolated uterus of the non-pregnant guinea-pig.
Topics: Adenosine Triphosphate; Animals; Female; Guinea Pigs; Indomethacin; Muscle Contraction; Muscle, Smoo | 1996 |